EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
691-710
Author(s):
Igor Astsaturov, Roger B. Cohen and Paul M. Harari
Meta Analysis of Advanced Cancer Survival Data Using Lognormal Parametric Fitting: A Statistical Method to Identify Effective Treatment Protocols
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
1533-1544
Author(s):
S. Qazi, D. DuMez and F. M. Uckun
Bone Seeking Radiopharmaceuticals for Palliation of Pain in Cancer Patients with Osseous Metastases
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
7
Page:
381-397
Author(s):
M.G.E.H. Lam, J.M.H. de Klerk, P.P. van Rijk and B.A. Zonnenberg
Antimicrobial Peptides in Oral Cancer
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3119-3130
Author(s):
Jens E. Meyer and Jurgen Harder
Synthetic Hammerhead Ribozymes as Therapeutic Tools to Control Disease Genes
Journal:
Current Gene Therapy
Volume:
5
Page:
11-24
Author(s):
L. Citti and G. Rainaldi
Isoprenylation of Intracellular Proteins as a New Target for the Therapy of Human Neoplasms: Preclinical and Clinical Implications
Journal:
Current Drug Targets
Volume:
6
Page:
301-323
Author(s):
M. Caraglia, A. Budillon, P. Tagliaferri, M. Marra, A. Abbruzzese and F. Caponigro
Melanoma Immunotherapy: Past, Present, and Future
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3461-3473
Author(s):
F. Saleh, W. Renno, I. Klepacek, G. Ibrahim, S. Asfar, H. Dashti, P. Romero, A. Dashti and A. Behbehani
Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
Journal:
Current Drug Targets
Volume:
6
Page:
665-682
Author(s):
K. Fjeldstad and S. O. Kolset
Targeting Cytotoxic Conjugates of Somatostatin, Luteinizing Hormone- Releasing Hormone and Bombesin to Cancers Expressing Their Receptors: A “Smarter” Chemotherapy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1167-1180
Author(s):
A. Nagy and A. V. Schally
Therapeutic Potential of Hammerhead Ribozymes in the Treatment of Hyper-Proliferative Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
369-386
Author(s):
G. Grassi, P. Dawson, G. Guarnieri, R. Kandolf and M. Grassi